333 South Grand Avenue
28th Floor
Los Angeles, CA 90071
United States
213 830 6300
https://www.oaktreespecialtylending.com
Sector(s): Financial Services
Industry: Credit Services
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Armen Panossian J.D. | CEO & Chief Investment Officer | N/A | N/A | 1976 |
Mr. Mathew M. Pendo | President | N/A | N/A | 1964 |
Mr. Aman Kumar | Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending | N/A | N/A | N/A |
Mr. Raghav Khanna | Managing Director & Co-Portfolio Manager | N/A | N/A | 1984 |
Mr. Christopher McKown | MD,CFO & Treasurer | N/A | N/A | 1982 |
Mr. Matthew Stewart C.F.A., CPA | MD & COO | N/A | N/A | 1985 |
Mr. Michael Mosticchio | Investor Relations | N/A | N/A | N/A |
Ms. Mary Gallegly | MD,General Counsel & Secretary | N/A | N/A | N/A |
Ms. Ashley Pak | Chief Compliance Officer | N/A | N/A | 1978 |
Mr. Sandeep Kumar Khorana | Managing Director of Origination | N/A | N/A | 1973 |
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
Oaktree Specialty Lending Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.